2019 logo_150x35_jpg.jpg
Novan Submits New Drug Application to the U.S. FDA for Berdazimer Gel, 10.3% (SB206) for the Treatment of Molluscum Contagiosum
January 06, 2023 08:00 ET | Novan, Inc.
– Potential FDA approval anticipated in first quarter 2024, assuming the filing is accepted by the FDA and under standard review timelines – – Molluscum contagiosum is a viral skin infection that...
2019 logo_150x35_jpg.jpg
EPI Health, a Novan Company, Enters into Exclusive License Agreement with Sato Pharmaceutical Co., Ltd. for RHOFADE® in Japan
December 21, 2022 08:00 ET | Novan, Inc.
DURHAM, N.C., Dec. 21, 2022 (GLOBE NEWSWIRE) -- Novan, Inc. (“the Company” or “Novan”) (Nasdaq: NOVN), today announced that EPI Health, LLC, a fully consolidated subsidiary of Novan, has entered...
AccurioShine 3600 with iFoil One
Konica Minolta lance l’AccurioShine 3600 avec iFoil One
December 14, 2022 11:00 ET | Solutions d’affaires Konica Minolta (Canada) Ltée
MISSISSAUGA, Ontario, 14 déc. 2022 (GLOBE NEWSWIRE) -- Solutions d’affaires Konica Minolta (Canada) Ltée (Konica Minolta), chef de file des solutions d’impression et d’emballage industrielles...
AccurioShine 3600 with iFoil One
Konica Minolta Launches AccurioShine 3600 + iFoil One
December 14, 2022 11:00 ET | Konica Minolta Business Solutions (Canada) Ltd.
MISSISSAUGA, Ontario, Dec. 14, 2022 (GLOBE NEWSWIRE) -- Konica Minolta Business Solutions (Canada) Ltd. (Konica Minolta), a leader in industrial and commercial printing and packaging solutions,...
2019 logo_150x35_jpg.jpg
EPI Health, a Novan Company, Executes a $15.0 Million Financing Agreement
December 02, 2022 08:00 ET | Novan, Inc.
– Agreement provides immediate access to cash flow – – EPI Health leveraging accounts receivables from commercial product sales to bolster working capital needs – DURHAM, N.C., Dec. 02, 2022 ...
2019 logo_150x35_jpg.jpg
Novan to Participate in the Cantor Fitzgerald Medical & Aesthetic Dermatology, Ophthalmology & Medtech Conference
December 01, 2022 09:00 ET | Novan, Inc.
– Paula Brown Stafford, President and Chief Executive Officer of Novan to participate in a live moderated panel discussion on Thursday, December 8th at 11:00 AM ET – DURHAM, N.C., Dec. 01, 2022 ...
Stephen J. Bonventre
EdgarAgents Names Stephen J. Bonventre as Chief Executive Officer
November 29, 2022 07:00 ET | Edgar Agents
NEW YORK, Nov. 29, 2022 (GLOBE NEWSWIRE) -- EdgarAgents LLC, one of the fastest growing financial technology service providers in the United States, has announced that its Board has appointed...
Figure 1
Balincan USA Inc. (BCNN) Letter to our Shareholders
November 18, 2022 00:00 ET | Balincan USA, Inc.
COLORADO SPRINGS, Colo., Nov. 18, 2022 (GLOBE NEWSWIRE) -- This is the BCNN Board of Directors letter to shareholders. To our Shareholders This is the first letter to our shareholders, and we are...
2019 logo_150x35_jpg.jpg
Novan Reports Third Quarter 2022 Financial Results and Provides Corporate Update
November 14, 2022 07:00 ET | Novan, Inc.
– Rhofade prescriptions increased 37% for third quarter year-to-date from prior year – – Continued progress toward submission of berdazimer gel, 10.3% (SB206) New Drug Application (NDA), targeted...
2019 logo_150x35_jpg.jpg
Novan to Report Third Quarter 2022 Financial Results on November 14, 2022
November 07, 2022 09:00 ET | Novan, Inc.
DURHAM, N.C., Nov. 07, 2022 (GLOBE NEWSWIRE) -- Novan, Inc. (“the Company” or “Novan”) (Nasdaq: NOVN), today announced that it will report its third quarter 2022 financial results on Monday,...